Learn / NVAX
NASDAQ: NVAX
Novavax (NVAX) stock, explained like you're 5
Novavax trades on the Nasdaq under the ticker NVAX. It is a mid cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 2.1 billion dollars.
- Ticker
- NVAX
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Biological Products (No Diagnostic Substances)
- Size
- Mid cap, about 2.1 billion dollars
Is Novavax a small, medium or large cap company?
No. Novavax is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 2.1 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Novavax makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves NVAX stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- NVAX Stock Rises Overnight Ahead Of Q4 Print With Pfizer Tailwinds Analyst Warns Of 20% Crash (Stocktwits)
- Why Moderna Stock, Novavax, and Revolution Medicines Are Slumping Today (Barron's)
- Is Novavax (NVAX) Expensive Or Cheap As Investors Reassess Vaccine Risk? (Simply Wall Street)
- Why is Novavax stock sliding today? (Investing.com)
- Novavax Plunges 12% as Selloff Hits Vaccine Makers; Moderna Tumbles 10%, Pfizer Holds Steady (24/7 Wall St.)
Follow NVAX in your daily brief
Each trading day at 5 PM ET we post what happened to Novavax and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow NVAX
Questions about Novavax stock
What does Novavax do?
Novavax trades on the Nasdaq under the ticker NVAX. It is a mid cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 2.1 billion dollars.
What is the ticker symbol for Novavax?
Novavax trades under the ticker NVAX on the Nasdaq.
What is Novavax's market cap?
Novavax is a mid cap stock with a market cap of about 2.1 billion dollars.
How does Novavax make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves NVAX stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow NVAX stock every day?
Add NVAX to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.